Ritedose Launches <em>Albuterol Sulfate Inhalation Solution 0.5% (5 mg/mL)</em> to Meet National Drug Shortage
COLUMBIA, S.C. (May 9, 2023) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose vial product, Albuterol Sulfate Inhalation Solution 0.5% (5 mg/mL). It is a ready-to-use drug shortage solution for hospital pharmacies across the country. Ritedose is a division of The Ritedose
Recent Comments